Idiopathic orbital inflammation: A pathogenetic construct and treatment strategy: The 2005 ASOPRS Foundation Lecture

Ophthalmic Plastic and Reconstructive Surgery

Volumn 22, Issue 2, 2006, Pages 79-86

  Harris, Gerald J ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACLIZUMAB; EFALIZUMAB; ETANERCEPT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIINFLAMMATORY AGENT;

B LYMPHOCYTE; CHEMOSIS; COMPARATIVE STUDY; CROHN DISEASE; DEMYELINATING DISEASE; EDEMA; ERYTHEMA; EXTRAOCULAR MUSCLE; EYE INFLAMMATION; EYE PAIN; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; IDIOPATHIC ORBITAL INFLAMMATION; IMMUNOGENICITY; LYMPHOCYTIC INFILTRATION; MYOSITIS; NONHUMAN; PLASMA CELL; PLASMAPHERESIS; PLASTIC SURGERY; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; TUBERCULOSIS; ARTICLE; BIOPSY; DIFFERENTIAL DIAGNOSIS; ORBIT GRANULOMA; PATHOLOGY;

ANTI-INFLAMMATORY AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; GRANULOMA, PLASMA CELL, ORBITAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 33646693661     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000203734.52333.93     Document Type: Review

References (26)

1. Ahn Yuen SJ, Rubin PAD. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 2003;121:491-9.
2. Rootman J. Orbital inflammatory disease: classification and new insights. In: Rootman J, ed. Orbital disease: present status and future challenges. London: Taylor & Francis; 2005:1-14.
3. Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol 1996;41:66-78.
4. Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol 2002;13:347-51.
5. Birch-Hirschfeld A. Die Krankheiten der Orbita. In: Graefe A, Saemisch T, eds. Handbuch der gesamten Augenheilkunde. vol 9. Berlin: Julius Springer; 1930:251-3.
6. Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology 1996;103:521-8.
7. Mahr MA, Salomao DR, Garrity JA. Inflammatory orbital pseudotumor with extension beyond the orbit. Am J Ophthalmol 2004;138:396-400.
8. 3d ed. Philadelphia: WB Saunders; 1986:2777-96.
9. McCarthy JM, White VA, Harris G, et al. Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis. Mod Pathol 1993;6:581-7.
10. Slavin ML, Glaser JS. Idiopathic orbital myositis: report of 6 cases. Arch Ophthalmol 1982;100:1261-5.
11. Purcell JJ, Taulbee WA. Orbital myositis after upper respiratory tract infection. Arch Ophthalmol 1981;99:437-8.
12. Weinstein GS, Dresner SC, Slamovits TL, Kennerdell JS. Acute and subacute orbital myositis. Am J Ophthalmol 1983;96:209-17.
13. Seidenberg, Leib ML. Orbital myositis with Lyme disease. Am J Ophthalmol 1990;109:13-6.
14. Klein BR, Hedges TR, Dayal Y, Adelman LS. Orbital myositis and giant cell myocarditis. Neurology 1989;39:988-90.
15. Young RSK, Hodes BL, Cruse RP, et al. Orbital pseudotumor and Crohn's disease. J Pediatrics 1981;99:250-1.
16. Ludwig I, Tomsak RL. Acute recurrent orbital myositis. J Clin Neuro-ophthalmol 1983;3:41-3.
17. Harris GJ, Murphy ML, Schmidt EW, et al. Orbital myositis as a paraneoplastic syndrome. Arch Ophthalmol 1994;112:380-6.
18. th ed, Philadelphia: Saunders; 2003:33-59.
19. th ed, Philadelphia: Saunders; 2003:103-64.
20. Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med 1999;341:2068-74.
21. Rubin PAD, Foster CS. Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol 2004;138:1041-3.
22. Hatton MP, Rubin PA, Foster CS. Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil. Am J Ophthalmol 2005;140:916-8.
23. Garrity JA, Coleman AW, Matteson EL, et al. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol 2004;138:925-30.
24. Wilson MW, Shergy WJ, Haik BG. Infliximab in the treatment of recalcitrant idiopathic orbital inflammation. Ophthal Plast Reconstr Surg 2004;20:381-3.
25. Stern DK, Tripp JM, Ho VC, Lebwohl M. The use of systemic immune moderators in dermatology: an update. Dermatol Clin 2005;23:259-300.
26. Nash PT, Florin THJ. Tumour necrosis factor inhibitors. Med J Aust 2005;183:205-8.